Nairametrics
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
  • Markets
    • Cryptos
    • Commodities
    • Equities
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Industries
    • Company News
    • Consumer Goods
    • Content Partners
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Tech News
  • Economy
    • Get Data
    • Macro-Economic News
    • Research Analysis
  • Business News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
No Result
View All Result
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
  • Markets
    • Cryptos
    • Commodities
    • Equities
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Industries
    • Company News
    • Consumer Goods
    • Content Partners
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Tech News
  • Economy
    • Get Data
    • Macro-Economic News
    • Research Analysis
  • Business News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
No Result
View All Result
Nairametrics
No Result
View All Result
Home Industries Content Partners

Emzor Pharmaceutical Industries Limited successfully completes its debut NGN13.73 billion 5-year corporate bond

NM Partners by NM Partners
January 27, 2021
in Content Partners
Stella Okoli: The woman who built a pharmaceutical giant from a small store
Share on FacebookShare on TwitterShare on Linkedin

Emzor Pharmaceutical Industries Limited (“Emzor” or “the Company”), the leading Nigerian pharmaceutical company, successfully launched its maiden ₦13.73 billion 5-year Fixed Rate Senior Unsecured Bond Issue due January 2026 under the Company’s ₦50.00 billion Bond Programme. The transaction represents Emzor’s debut bond issuance.

The offering was preceded by a comprehensive credit positioning and marketing exercise which enabled the successful issuance despite uncertain monetary policy and benchmark rate direction and the Christmas holidays. Following approval from the Securities and Exchange Commission, book building with respect to the transaction commenced during the Christmas holidays and closed on the 12th of January 2021. The bond saw solid interest from a diverse pool of institutional investors with Pension Funds (61%) and Asset Managers (31%) dominating the orderbook and final allocation. The issue was priced at a coupon rate of 10.00% per annum, highlighting Emzor’s strong investment-grade ratings- the Issuer and Issue were rated A- (stable outlook) and A (stable outlook) by GCR and DataPro, respectively.

The net proceeds of the bond will enable Emzor further expand its existing operations as well as to expand into several new lines, mainly at its new and ultra-modern manufacturing campus at Sagamu in Ogun State, whilst supplementing its working capital.

RelatedPosts

Emzor Pharmaceuticals accesses capital markets for the first time, lists N13.7bn Bond on NGX

Speaking on the significance and success of the bond issue, Dr Stella Okoli, Group Managing Director of Emzor commented: “This first-time bond issuance is a fantastic achievement for Emzor and in our commitment to unlimited wellness for all by delivering quality medicines for all and affordable by all, a key part of our Wellocracy programme. This will help drive and accelerate our expansion plans, delivering strong growth and margin improvement. It is important that our industry in Nigeria and on the continent continue to increase capacity and
capability in order to reach the goal of self-sufficiency in pharmaceutical manufacturing, thereby reducing the dependency on imports. We recognise the efforts of the investor community ensuring the success of this bond issuance and commit to uphold their confidence in us as we deliver on our long-term growth strategy.”

Renaissance Capital acted as Lead Issuing House and Ratings Adviser, with Afrinvest as Joint Issuing House for Emzor’s bond issue.

About Emzor

Emzor is the leading Nigerian pharmaceutical company, established in 1984 by Dr. Stella Okoli. The principal activity of the Company is the manufacturing and distribution of high-quality pharmaceutical and healthcare products. The Company is the manufacturer of the widely known Emzor Paracetamol which is one of the leading brands of analgesics in Nigeria. From producing 4 products in 1987, the Company has grown its product base to over 200 products spread across 26 different categories including but not limited to analgesics, antimalarial, antibiotics, multivitamins, antitussives, antifungal, antihistamines and antihypertensives.

The Company serves its customers via over 160 distributors spread across over 25 countries in West Africa with a solid operational presence in Nigeria, Liberia and Sierra Leone. Emzor currently operates from 4 factories of which three sites are Aswani, Ajao and Richfield located in Lagos whilst the fourth factory is located in Sagamu, Ogun State.

The Company has strong relationships with international suppliers and technical partners, which has supported solid competitive positioning. Emzor has a diversified earnings profile supported by ongoing product innovation and an expanding retail footprint. For additional information on the Company, please visit www.emzorpharma.com

Related

Tags: Emzor Pharmaceutical Industries Limited

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Mega Millions
Hot forex
Cornerstone
Polaris Bank
Access Bank
Bankers Committee
First bank


FCMB




    Business News | Stock Market | Money Market | Cryptos | Financial Literacy | SME |

    Recent News

    • Citigroup says oil prices may crash to $65 by end of 2022 due to recession
    • Nigeria’s stock market closes bearish as market capitalization dips by N110 billion
    • IPOB disowns Peter Obi’s presidential bid, says he was never their member

    Follow us on social media:

    Recent News

    Crude oil, Oil down as China releases fuel reserves, Oil down as China releases fuel reserves

    Citigroup says oil prices may crash to $65 by end of 2022 due to recession

    July 5, 2022
    Bears market

    Nigeria’s stock market closes bearish as market capitalization dips by N110 billion

    July 5, 2022
    • ABOUT US
    • CONTACT US
    • PRODUCTS
    • ANDROID APP
    • iOS APP
    • DISCLAIMER
    • CAREERS
    • PRIVACY POLICY

    © 2022 Nairametrics

    No Result
    View All Result
    • Home
    • Exclusives
      • Financial Analysis
      • Corporate Stories
      • Interviews
      • Investigations
      • Metrics
    • Markets
      • Cryptos
      • Commodities
      • Equities
        • Dividends
        • Stock Market
      • Fixed Income
      • Market Views
      • Securities
    • Industries
      • Company News
      • Consumer Goods
      • Content Partners
      • Corporate deals
      • Corporate Press Releases
      • Energy
      • Entertainment
      • Financial Services
      • Hospitality & Travel
      • Manufacturing
      • Real Estate and Construction
      • Tech News
    • Economy
      • Get Data
      • Macro-Economic News
      • Research Analysis
    • Business News
    • Financial Literacy
      • Career tips
      • Personal Finance
    • Lifestyle
      • Billionaire Watch
      • Profiles
    • Opinions
      • Blurb
      • Op-Eds

    © 2022 Nairametrics

    Social Media Auto Publish Powered By : XYZScripts.com